APA aipamena

Peterson, L. M., Kurland, B. F., Schubert, E. K., Link, J. M., Gadi, V., Specht, J. M., . . . Linden, H. M. (2013). A Phase 2 Study of 16α-[(18)F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).

Chicago Style aipamena

Peterson, Lanell M., et al. A Phase 2 Study of 16α-[(18)F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) As a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC). 2013.

MLA aipamena

Peterson, Lanell M., et al. A Phase 2 Study of 16α-[(18)F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) As a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC). 2013.